about
The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer DrugsProliferation and motility of hepatocellular, pancreatic and gastric cancer cells grown in a medium without glucose and arginine, but with galactose and ornithineIbrutinib-induced severe liver injury.Incidence and risk of regorafenib-induced hepatotoxicity.Diclofenac sex-divergent drug-drug interaction with Sunitinib: pharmacokinetics and tissue distribution in male and female mice.Sunitinib-paracetamol sex-divergent pharmacokinetics and tissue distribution drug-drug interaction in mice.Role of Cytochrome P450 Enzymes in the Metabolic Activation of Tyrosine Kinase Inhibitors
P2860
Q26801532-CDC35B8F-8094-4EB4-8B32-F5003C97736AQ33598120-2091A9E2-2A61-45AC-B3F1-863B5E143E8CQ41811786-172F7233-016B-4B0F-B201-612DF7FE1B1AQ45800216-3CB7024C-9E3A-4DD7-B131-D743C00FBE59Q47831824-CE3BE261-666B-4709-956A-6B3805909B7BQ47895186-B90B7A2C-1FE8-4DC0-B570-DFBA9317E3E3Q58788266-1EFBE81F-EF9E-4AB1-877A-468D940F3A78
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Hepatotoxicity of molecular targeted therapy.
@ast
Hepatotoxicity of molecular targeted therapy.
@en
type
label
Hepatotoxicity of molecular targeted therapy.
@ast
Hepatotoxicity of molecular targeted therapy.
@en
prefLabel
Hepatotoxicity of molecular targeted therapy.
@ast
Hepatotoxicity of molecular targeted therapy.
@en
P2860
P356
P1476
Hepatotoxicity of molecular targeted therapy.
@en
P2093
Agata Sałek-Zań
Bożenna Karczmarek-Borowska
P2860
P356
10.5114/WO.2014.43495
P577
2014-08-29T00:00:00Z